The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Start Date
1/1/2022
Completion Date
10/1/2026
Summary
The study is designed as an international, multicenter prospective cohort study. Patients with presumed glioblastoma (GBM) in- or near eloquent areas on diagnostic MRI will be selected by neurosurgeons. Patients will be treated following one of three study arms: 1) a craniotomy where the resection boundaries for motor or language functions will be identified by the "awake" mapping technique (awake craniotomy, AC); 2) a craniotomy where the resection boundaries for motor functions will be identified by "asleep" mapping techniques (MEPs, SSEPs, continuous dynamic mapping); 3) a craniotomy where the resection boundaries will not be identified by any mapping technique ("no mapping group"). All patients will receive follow-up according to standard practice.
Eligibility Criteria
Age Range: 18 years to 90 years
Interventions
Awake mapping under local anesthesia
Asleep mapping under general anesthesia
Resection under general anesthesia without mapping
Conditions
Locations
University of California, San Francisco
San Francisco, California 94143
United States
Massachusetts General Hospital
Boston, Massachusetts 02114-2696
United States
University Hospitals Leuven
Leuven, Vlaams-Brabant 3000
Belgium
University Hospital Heidelberg
Heidelberg,
Germany
Technical University Munich
Munich,
Germany
Erasmus MC
Rotterdam, South Holland 3015 CE
Netherlands
Medical Center Haaglanden
The Hague, South Holland 2261 CP
Netherlands
Inselspital Universitätsspital Bern
Bern,
Switzerland